Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Net Margin (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Net Margin for 17 consecutive years, with 8.69% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 807.0% to 8.69% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 14.64% through Dec 2025, up 3337.0% year-over-year, with the annual reading at 14.64% for FY2025, 3314.0% up from the prior year.
  • Net Margin for Q4 2025 was 8.69% at Bristol Myers Squibb, down from 17.96% in the prior quarter.
  • The five-year high for Net Margin was 21.98% in Q1 2025, with the low at 100.36% in Q1 2024.
  • Average Net Margin over 5 years is 8.38%, with a median of 13.85% recorded in 2022.
  • The sharpest move saw Net Margin tumbled -12036bps in 2024, then soared 12234bps in 2025.
  • Over 5 years, Net Margin stood at 19.79% in 2021, then fell by -10bps to 17.75% in 2022, then dropped by -16bps to 14.87% in 2023, then crashed by -96bps to 0.62% in 2024, then surged by 1311bps to 8.69% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 8.69%, 17.96%, and 10.7% for Q4 2025, Q3 2025, and Q2 2025 respectively.